With the patent concentration of a large number of "heavy drugs" in the world,Chinese pharmaceutical companies will usher in huge development opportunities。On the International Biomedical and Medical Devices Forum held in Wuhan a few days ago,Expert prediction,By 2020,The total output value of my country's pharmaceutical industry will reach 10 trillion,ranked second in the world。

 

Will on the way,More than 200 people from North America、Australia、European and other overseas regions and domestic guests around the trend and trend of my country's pharmaceutical industry、Policies and regulations and status quo of the development of new drugs、The hot issues of biomedical fields such as biological industry stake online sports bettingtransfer and capital operation have been discussed。

 

Former Minister of the Drug Evaluation Center of the State Food and Drug Administration、Shao Ying, a senior researcher at Peking University, introduced on the forum,For the past ten years,The average growth rate of China's pharmaceutical industry is 16.4%.,The average growth rate will reach 23.6%. He expects,Under the background of the country's vigorous promotion of a healthy development plan,There is huge market demand in the field of biomedical。In the next few years,China is expected to become the third largest pharmaceutical market in the world after the United States and Japan。

 

It is the huge market potential,Including GlaxoSmot、Pfizer、Novartis and other multinational pharmaceutical companies have set up R & D centers in China。At the same time,To further promote industrial development,stake online sports bettingmy country has listed biomedicine as a strategic emerging industry ,It has formulated the "Several Policies to Promote the Accelerated Development of the Biological Industry"、"Special Plan for" Major New Medicine Creation "Technology and Technology,Strive to develop into a biotechnology power and a big country of biotechnology during the "Twelfth Five -Year Plan" period。